Novel cancer drug reduces neuroblastoma growth by 75 percent

Researchers from the Children's Cancer Hospital at The University of Texas M. D. Anderson Cancer Centre have found a new drug that restricts the growth of neuroblastoma, a childhood brain cancer. The pre-clinical study was presented today in the plenary session at the 22nd annual meeting of the American Society of Pediatric Hematology/Oncology...

Read the whole article on

More from